Yatai Pharm released its performance for the first half of the year, with a net profit attributable to the parent company of 105 million yuan, an increase of 1820.97%

According to the Zhitong Finance APP, Yatai Pharm (002370.SZ) released its semi-annual report for 2025, showing an operating income of 152 million yuan, a year-on-year decrease of 31.48%. The net profit attributable to shareholders of the listed company was 105 million yuan, a year-on-year increase of 1820.97%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 48.8622 million yuan, a year-on-year increase of 524.31%. The basic earnings per share were 0.14 yuan